Covid-19

Britain authorizes Merck’s Molnupiravir, the world’s first approval of oral covid-19 treatment pill. The drug is waiting for FDA review and approval. Britain became the first country in the world to approve a potentially game-changing Covid-19 antiviral pill jointly developed by US drugmaker Merck and Ridgeback Biotherapeutics, i...
FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID19 to include children 5 through 11 years of age.  Key points: Effectiveness: Immune responses of children 5 through 11 years of age were comparable to those of individuals 16 through 25 years of age. In addition, t...
FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID19 to include children 5 through 11 years of age.  Key points: Effectiveness: Immune responses of children 5 through 11 years of age were comparable to those of individuals 16 through 25 years of age. In addition, t...
Antibiotics treatment for bacterial pneumonia in adults in hospital  Antibiotic management of suspected or confirmed bacterial pneumonia in adults in hospital during the COVID-19 pandemic. This includes people presenting to hospital with moderate to severe community-acquired pneumonia and people who develop pneumonia while in hospital.COVID...
Pfizer’s COVID-19 vaccine could be authorized for ages 5-11 by the end of October, according to Reuters. FDA may authorize COVID-19 vaccine for kids based on two months of safety data. The timeline is based on the expectation that Pfizer will have enough data from clinical trials to request FDA emergency use authorization for the age group nea...
A new draft recommendation relating to anticoagulation for discharged patients with COVID-19 has been issued by the American Society of Hematology (ASH).For patients with COVID-19 who are being discharged from the hospital and who do not have suspected or confirmed venous thromboembolism or another indication for anticoagulation, the ASH guide...
A new draft recommendation relating to anticoagulation for discharged patients with COVID-19 has been issued by the American Society of Hematology (ASH).For patients with COVID-19 who are being discharged from the hospital and who do not have suspected or confirmed venous thromboembolism or another indication for anticoagulation, the ASH guide...
Covid-19 has spread and had a profound effect on the lives and health of people around the globe.Recent evidence shows that a range of symptoms can remain after the clearance of the acute infection in many people who have had covid-19, and this condition is known as long covid.The National Institute for Health and Care Excellence (NICE) defines...
The U.S. Food and Drug Administration authorizes bamlanivimab and etesevimab, administered together, to include emergency use as post-exposure prophylaxis (prevention) for COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) who are at high risk for progression to severe COVID-19, including hospitalizat...
Association between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 Viral infections are a common cause of myocarditis, an inflammation of the heart muscle (myocardium) that can result in hospitalization, heart failure, and sudden death. Emerging data suggest an association between...
Russian health officials have approved a single-dose version of the Sputnik V vaccine. Sputnik Light has showed nearly 80 per cent efficacy in tests. The single dose Sputnik Light vaccine demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered as part of Russia’s mass vaccination program...
A study by the University of Oxford, published in the journal Cell, demonstrates that currently available vaccines, including AstraZeneca’s COVID-19 vaccine, will provide protection against the  Delta (B.1.617.2) and Kappa (B1.617.1) variants; formerly the ‘Indian’ variants. The study, investigated the ability of antibodies in the blood of...